Followers | 7 |
Posts | 6082 |
Boards Moderated | 0 |
Alias Born | 03/19/2017 |
Thursday, March 14, 2019 11:04:06 PM
Friedman, in his former role at the different company claimed to have property in....wait for it....California, Colorado and Puerto Rico (IIRC, he was also going to open up a MJ B&B in Nowheresville, Quebec, Canada, but I doubt he ever did).
PR is wrong. Epidiolex was approved June 2018, not “earlier this year.”
WHO is not recommending “descheduling” anything....”descheduling” isn’t even a word. They probably meant “rescheduling,” but it, along with a couple of other grammar miscues demonstrates what appears to be some slapdash authoring.
A simple search of the intertubes shows about 10 different companies at the address listed on the company’s website. Either all of those companies are there, it’s a lawyer’s office or a P.O. Box address.
There are very few specifics laid out in the PR. Who are the labs? How much was actually ordered (for starters).
This PR has the same feel as Friedman’s previous company.
Agree there could be a small pop to get some money back or quick profits, but as for this company being investment grade.....lol.
Recent MBAIF News
- Emerging Markets Report: Meeting the Moment • InvestorsHub NewsWire • 11/21/2023 04:18:47 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM